← Back to Search

Behavioural Intervention

First Responders for Hemoglobinopathy

N/A
Waitlist Available
Led By Kimberly Mueller, PhD, CCC-SLP
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-test (baseline), 3 to 6 month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This study aims to determine the impact of a collaborative approach to training law enforcement officers and first responders about aphasia including their knowledge and confidence in communicating with individuals with aphasia that they may encounter in the field. 75 participants from Madison Police Department will be enrolled and can expect to be on study for up to 6 months.

Who is the study for?
This trial is for first responders and law enforcement officers employed by the Madison Police Department who are willing to learn about aphasia, consent to participate, and can commit to the study procedures for up to 6 months.
What is being tested?
The study tests a training program aimed at improving knowledge and confidence among police officers when communicating with individuals affected by aphasia they may meet during their duties.
What are the potential side effects?
Since this trial involves educational training rather than medical or drug interventions, there are no direct physical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-test (baseline), 3 to 6 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-test (baseline), 3 to 6 month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
First Responder Aphasia Training Score
First Responder Confidence in Communication Score
First Responder Strategies for Aphasia

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: First RespondersExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,228 Previous Clinical Trials
3,198,463 Total Patients Enrolled
Kimberly Mueller, PhD, CCC-SLPPrincipal InvestigatorUniversity of Wisconsin, Madison
~50 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top